Seth Ginsberg, co-founder and president of the Global Healthy Living Foundation, explains what patients should know about biosimilar therapies. http://www.centerforbiosimilars.com/interviews/seth-ginsberg-what-patients-need-to-know-about-biosimilars

Pfizer offers a patient-friendly explanation of biosimilars – what they are, how they differ from generics, and how they are developed and approved, among other topics on the company’s biosimilars website. Read more.

By 2020, the global biosimilars market is expected to top $390 billion and account for up to 28 percent of the global market for pharmaceuticals, due in large part to the loss of patent protection for commercially successful drugs. Read more.